While Tango Therapeutics Inc has underperformed by -1.57%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TNGX rose by 123.30%, with highs and lows ranging from $12.02 to $1.03, whereas the simple moving average jumped by 101.36% in the last 200 days.
On August 19, 2025, Piper Sandler started tracking Tango Therapeutics Inc (NASDAQ: TNGX) recommending Overweight. A report published by Jefferies on July 17, 2024, Initiated its previous ‘Buy’ rating for TNGX. Piper Sandler Initiated an Overweight rating on February 12, 2024, and assigned a price target of $18. B. Riley Securities initiated its ‘Buy’ rating for TNGX, as published in its report on December 08, 2023. H.C. Wainwright’s report from October 20, 2022 suggests a price prediction of $10 for TNGX shares, giving the stock a ‘Buy’ rating. SVB Leerink also rated the stock as ‘Outperform’.
Analysis of Tango Therapeutics Inc (TNGX)
Further, the quarter-over-quarter decrease in sales is -83.99%, showing a negative trend in the upcoming months.
Tango Therapeutics Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -76.09% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.75, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and TNGX is registering an average volume of 2.66M. On a monthly basis, the volatility of the stock is set at 7.86%, whereas on a weekly basis, it is put at 7.15%, with a gain of 1.92% over the past seven days. Furthermore, long-term investors anticipate a median target price of $10.88, showing growth from the present price of $6.9, which can serve as yet another indication of whether TNGX is worth investing in or should be passed over.
How Do You Analyze Tango Therapeutics Inc Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 44.82%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 73.25% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
